Clincosm LogoSign in Get a demo

Effect of Educational Program About Preventive Care Bundle for Prevention of Ventilator Associated Pneumonia Among Newborns

Sponsor
Damanhour University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06066489
Collaborator
(none)
137
Enrollment
2
Arms
5
Anticipated Duration (Months)

Study Details

Study Description

Brief Summary

This study is designed to investigate the effect of educational program for nurses about preventive care bundle for prevention of ventilator associated pneumonia among newborns.

Condition or Disease Intervention/Treatment Phase
  • Other: educational program about VAP
 N/A

Detailed Description

Neonatal ventilator associated pneumonia (VAP) is a common nosocomial infection and a frequent reason for empirical antibiotic therapy in NICUs. Ventilator associated pneumonia (VAP) is defined as a nosocomial lower airway infection in intubated patients with onset after 48 h or more of invasive mechanical ventilation.Prevention of VAP has been primarily achieved by the "bundle approach"; this involves the simultaneous application of several preventive strategies for all patients.In Egypt and other developing countries, reports on the success of VAP intervention strategies, particularly among neonates, are scarce. So, it is important to conduct educational programs for nurses about VAP to decrease its incidence.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
137 participants
Allocation:
Non-Randomized
Intervention Model:
Sequential Assignment
Intervention Model Description:
A prospective, quasi-experimental, pre- and post-study with a one month baseline period; one month intervention period and three months post-intervention periodA prospective, quasi-experimental, pre- and post-study with a one month baseline period; one month intervention period and three months post-intervention period
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Effect of Educational Program for Nurses About Preventive Care Bundle for Prevention of Ventilator Associated Pneumonia Among Newborns
Anticipated Study Start Date :
Oct 1, 2023
Anticipated Primary Completion Date :
Feb 1, 2024
Anticipated Study Completion Date :
Mar 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Nurses

Nurses will be assessed first about their knowledge about VAP then they will receive an educational program about VAP and will be assessed immediately and 3 months after the program

Other: educational program about VAP
An educational program about VAP that includes VAP bundle from CDC as core measures , equipment related measures and general measures.
Experimental: newborns

the prevalence of VAP will be assessed among all ventilated newborns who will meet inclusion criteria in the study before implementing the program, immediately and 3 months after the program using PNU1

Other: educational program about VAP
An educational program about VAP that includes VAP bundle from CDC as core measures , equipment related measures and general measures.

Outcome Measures

Primary Outcome Measures

  1. prevalence of VAP among newborns ( the number of newborns diagnosed with VAP during the study period [before intervention as baseline ( Day 1), immediately after the intervention, 3 months later after intervention]

    prevalence of VAP will be compared before application of educational program for nurses about preventive care bundle for prevention of VAP and after the program ( immediately, 3 months later) by using centers for disease control and prevention PNU-1

Secondary Outcome Measures

  1. nurses practices about prevention of ventilator associated pneumonia after implementing the training program will be compared by their practices before the intervention using Observational Checklist [before intervention as baseline(Day 1), immediately after the intervention, 3 months later after intervention]

    nurses practices will be assessed before and after the intervention immediately and 3 months later using Observational Checklist about their practices and then results compared before and after the intervention by mean percent score

Eligibility Criteria

Criteria

Ages Eligible for Study:
3 Days to 30 Days
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

  • Gestational age ≥34 weeks

  • Intubated newborns and those expected to receive mechanical ventilation for more than 48 hours.

Exclusion Criteria:

  • Newborns with diagnosis of pneumonia at the time of admission.

  • Newborns developed pneumonia in the first 48 hours of mechanical ventilation.

  • Newborns subjected to reintubation.

  • Immunosuppressed newborns.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Damanhour University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Basma Ibrahim, lecturer, Damanhour University
ClinicalTrials.gov Identifier:
NCT06066489
Other Study ID Numbers:
  • VAP in newborns
First Posted:
Oct 4, 2023
Last Update Posted:
Oct 6, 2023
Last Verified:
Oct 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Basma Ibrahim, lecturer, Damanhour University
newborn
Additional relevant MeSH terms:
Pneumonia
Pneumonia, Ventilator-Associated

Study Results

No Results Posted as of Oct 6, 2023